Skip to content

Effect of Medication Adherence-Based Digital Intervention on Fatigue Severity, Weight, and Thyroid Hormone Regulation

Effect of Medication Adherence-Based Digital Intervention on Fatigue Severity, Weight, and Thyroid Hormone Regulation in Patients With Hypothyroidism: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07636681
Enrollment
80
Registered
2026-06-09
Start date
2026-06-01
Completion date
2026-12-30
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothyroidism

Brief summary

1. To evaluate the effect of a medication adherence-based digital intervention on fatigue severity in patients with hypothyroidism. 2. To assess the effect of a medication adherence-based digital intervention on weight in patients with hypothyroidism. 3. To investigate the effect of a medication adherence-based digital intervention on thyroid hormone regulation in patients with hypothyroidism.

Interventions

OTHERmedication adherence based digital intervention

participants in the intervention group will receive digital support aimed at improving their adherence to prescribed medications. This support will include a smartphone application developed specifically for the study, as well as reminder messages via WhatsApp to prompt participants to take their levothyroxine at the scheduled times

Sponsors

University of Baghdad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adults (≥18 years) with primary hypothyroidism. * On stable levothyroxine therapy for at least 3 months. * Able to read, understand study instructions * capable of using basic mobile applications * poor medication adherence, clinically significant fatigue, documented weight fluctuations and abnormal thyroid hormone

Exclusion criteria

* Secondary hypothyroidism or recent thyroidectomy/radioactive iodine therapy. * Pregnancy or breastfeeding woman. * Severe psychiatric disorders or cognitive impairment * significant visual or hearing deficits * Serious comorbidities affecting medication adherence (e.g., chronic disease, renal, or hepatic disease). * take dietary supplements or medications that interfere with levothyroxine absorption.

Design outcomes

Primary

MeasureTime frameDescription
Change in Fatigue Severity ScoreBaseline and 3 months after interventionAssessment of the effectiveness of a medication adherence-based digital intervention on fatigue severity by using the Fatigue Severity Scale (FSS).
Change in Body WeightBaseline and 3 months after intervention.Assessment of the effectiveness of a medication adherence-based digital intervention on weight by assessment of changes in Body Mass Index (BMI), calculated as weight in kilograms divided by height in meters squared (kg/m²).
Change in Thyroid Hormone LevelsBaseline and 3 months after intervention.Assessment of the effectiveness of a medication adherence-based digital intervention on Thyroid Hormone Levels by assessment of serum Thyroid Stimulating Hormone (TSH) and Free Thyroxine (FT4) levels.

Countries

Iraq

Contacts

CONTACTShahad Sabah Khudhair
shahed.sabbah1202a@conursing.uobaghdad.edu.iq9647737721360

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026